biophyll

What biophyll does

Biophyll GmbH is a privately held German company headquartered in Dietersburg, Bavaria, that sources, trades, manufactures, and develops biological products of animal, human, and plant origin on behalf of customers for pharmaceutical, diagnostic, and scientific applications. The company operates a horizontal B2B distribution and custom-manufacturing platform built around three product lines — human biological products (human serum albumin, human serum, human plasma, disease state plasma, other human-derived fractions), animal biological products (bovine serum albumin, bovine serum in multiple grades, horse plasma, animal sera from goat/sheep/porcine/mouse/rat, erythrocytes, globulins, enzymes, tissues, organs), and other biological products (dextran, dextran sulphate, IMO, plant-derived products, recombinant manufactured products). All products are produced under a Quality Management System with fully traceable batch manufacturing records and accompanying Certificates of Analyses, and the company holds TRACES registered European warehousing plus all required approvals for handling animal by-products (Veterinary Registration DE09 275 0005 37). Sourcing is executed through a global network of manufacturing partners spanning Australia, New Zealand, the United States, Canada, Mexico, Argentina, Chile, Brazil, China, broader Asia, and the European Union, with door-to-door shipping, customs and veterinary clearance, and regulatory advisory bundled into the service offering.

The company's go-to-market is consultative, sales-led, and quote-based, with pricing undisclosed publicly and payment terms of 30 days from invoice. Its primary customer segments include pharmaceutical companies, in vitro diagnostic (IVD) manufacturers, researchers and cell-culture users, medical device manufacturers, medicinal product manufacturers, cosmetics manufacturers, and food supplement manufacturers. Beyond product distribution, Biophyll operates an R&D function that has produced the Act-O2-Hem initiative — an active hemoglobin product developed jointly with Austrian partner M bioserviceS, positioned as the basis for the world's first artificial oxygen carrier for human use — and participates in European and German government-funded research programs (EFRE, BMBF, BMWi, ZIM, FFG, Eurostars-Eureka) alongside institutional partners including Charité and Serana.

The business model is essentially a specialized biological-materials trading and contract manufacturing operation with embedded logistics and regulatory compliance services. The company appears to be independently operated with no disclosed outside investment, no parent entity, and no public capital markets activity. Its senior leadership is led by Managing Director Dr. Peter Häusl, and its operating footprint covers more than 30 countries globally, with a current expansion focus on establishing a China–EU logistics corridor for sensitive biological raw materials under the Bavaria 3.0 – Go International program.

Name

biophyll

Legal name

Biophyll GmbH

Website

https://biophyll.com

Company type

Private

Operating status

Operating

Short description

Biophyll GmbH is a German B2B company that sources, trades, manufactures, and develops animal, human, and plant-derived biological raw materials and custom-manufactured products for pharmaceutical, diagnostic, and scientific customers across more than 30 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Diagnostic Biological Raw Materials

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Chemical and Allied Products Merchant Wholesalers (4246)

SIC

Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Biologics & Biosimilars Distributors (HLAIAJAH)

akta.pro secondary industry

Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ)

Keywords

• Biological raw materials
• Pharmaceutical raw materials
• Diagnostic components
• Custom biological manufacturing
• Animal by-products sourcing

Headquarters

HQ city

Dietersburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Biological Products Sales: Sale of biological raw materials including bovine serum albumin, human serum albumin, animal sera, dextran, human plasma, and other blood-derived products. Products are manufactured according to customer specifications and are fully traceable and quality tested.
2. Custom Manufacturing: Customized manufacturing of rare products tailored to customer specifications. Biophyll can produce almost any quantity of custom and semi-custom products within reasonable timeframes.
3. Sourcing and Logistics Services: Sourcing, transportation, import/export, handling, regulatory advice, customs clearance, and supply chain financing services. Includes TRACES registered European warehousing, door-to-door shipping solutions, and regulatory compliance support.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Biophyll sources, trades, manufactures, and develops biological products of animal, human, and plant origin on behalf of customers for pharmaceutical, diagnostic, and scientific purposes. The company provides access to rare biological raw materials worldwide, custom manufacturing of biological products to customer specifications, and integrated logistics including TRACES-registered European warehousing, customs clearance, and regulatory support.

Product overview

Biophyll is a biological products company operating across three integrated areas: product sourcing/trading, manufacturing, and research/development. The core product portfolio spans three categories—Human Biological Products (including Human Serum Albumin, Human Serum, Human Plasma, Disease State Plasma, and other human-derived fractions), Animal Biological Products (including Bovine Serum Albumin, Bovine Serum, Animal Sera, Horse Plasma, and other animal-derived products), and Other Biological Products (including Dextran, Dextran Sulphate, IMO, plant-derived products, and recombinant manufactured products). The company also offers specialized services including sourcing, transportation, import/export, regulatory advice, and customized manufacturing of rare biological products. The Act-O2-Hem product (active hemoglobin for oxygen carrier applications) represents their proprietary development. All products are manufactured according to customer specifications, fully traceable, and quality tested under a Quality Management System.

Differentiator

Problem solved

Functional benefit

Brands

• Act-O2-Hem: Active hemoglobin product with high ability to bind oxygen and serve as an oxygen carrier for in vitro and in vivo applications.
• Sure Component

Products and services

• Human Serum Albumin Human-derived serum albumin protein product for pharmaceutical, diagnostic, and scientific applications.
• Human Serum Human-derived serum product for pharmaceutical, diagnostic, and scientific applications.
• Human Plasma Human plasma product sourced and distributed worldwide for biopharmaceutical purposes.
• Disease State Plasma Specialized human plasma products with specific disease markers for diagnostic and research applications.
• Other Human Derived Products Additional human blood fractions, enzymes, and tissues for pharmaceutical, diagnostic, and scientific use.
• Bovine Serum Albumin Animal-derived serum albumin available in standard grade, protease free, fatty acid free and other grades; supplied lyophilized and liquid from US origin.
• Bovine Serum Animal serum including fetal, newborn, calf, donor and adult bovine serum in raw and processed forms from US, Australia, New Zealand, South America, and EU origins.
• Horse Plasma Horse plasma products including donor horse serum and horse serum from US and EU origins.
• Animal Sera Various animal sera including goat, sheep, porcine, mouse, rat, and other animal sera from US, EU and other origins.
• Other Animal Derived Products Animal products including erythrocytes, globulins, enzymes, tissues, and organs collected and processed according to customer requirements or own standards.
• Dextran Polysaccharide product available in various grades as powder, manufactured enzymatically from Asian origin.
• Dextran Sulphate Lyophilized dextran sulphate product for research and industrial applications.
• IMO – Iso Malto-Oligosaccharide Isomalto-oligosaccharide product marketed as beverage and food supplement ingredient.
• Other Plant Derived Products Plant-derived products collected and processed according to customer requirements for food supplements and other ingredients from worldwide origins.
• Recombinant Manufactured Products Recombinant products processed according to customer requirements using recombinant manufacturing technology.
• Act-O2-Hem Active hemoglobin product with high oxygen-binding ability, serving as an oxygen carrier for in vitro and in vivo applications in human and animal cell cultures.
• Sourcing and Trading Services Comprehensive biological product sourcing, transportation, import, export, and handling services with regulatory advice for pharmaceutical, diagnostic, and scientific purposes.
• Customized Manufacturing Services Customized manufacturing of rare biological products tailored to customer specifications, with manufacturing partners located worldwide (Australia, New Zealand, US, Canada, Mexico, Argentina, Chile, Brazil, China, Asia, EU).

Segments7 records

Ideal customer profiles7 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• M bioserviceScoreStrategic or Co-development PartnerAustrian partner company assisting biotech companies worldwide in sourcing, importation and handling activities. Collaborates on Act-O2-Hem project (active hemoglobin product) and Sure Component (intelligent biotech solutions).
• Act-O2-HemmajorStrategic or Co-development PartnerActive hemoglobin product with high ability to bind oxygen and deliver it to human and animal cells or cell cultures. Suitable as oxygen carrier for in vitro and in vivo applications including world's first artificial oxygen carrier for human use.
• Sure ComponentminorStrategic or Co-development PartnerYoung company introducing intelligent solutions for the biotech market. Strategic partner for innovative biotech product development.
• SeranamajorStrategic or Co-development PartnerProject partner in national project for manufacturing qualified and stabilized Hemoglobin-Enzyme-Solutions for medical or pharmaceutical use.
• CharitémajorStrategic or Co-development PartnerPrestigious German university medical institution collaborating on blood-derived product research and development projects.
• European Union (EFRE)coreOthersEuropean Regional Development Fund supporting Biophyll's operations and international expansion projects including China logistics chain development for sensitive biological materials.
• BMBF (Bundesministerium für Bildung und Forschung)majorOthersGerman Federal Ministry of Education and Research sponsoring European research projects on blood-derived products including hemoglobin applications.
• BMWi (Bundesministerium für Wirtschaft und Energie)majorOthersGerman Federal Ministry for Economic Affairs and Energy supporting research and development initiatives.
• FFG (Österreichische Forschungsförderungsgesellschaft)minorOthersAustrian Research Promotion Agency supporting international biotech research collaborations.
• Eurostars-EurekaminorOthersEuropean joint program co-funding research and innovation projects supporting Biophyll's international development.
• ZIM (Zentrales Innovationsprogramm Mittelstand)minorOthersCentral Innovation Programme for SMEs supporting mid-size enterprise innovation projects.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Caisson Laboratories: US-based manufacturer and distributor of cell culture media, sera, and biological inputs for research and biopharma. Comparable product range (sera, media components, plant-derived inputs) and B2B distribution model targeting diagnostics and pharma manufacturers.
• Moregate BioTech: Australian-origin supplier of fetal bovine serum and animal sera with global distribution to diagnostics, research, and biopharma markets. Closely comparable to Biophyll on origin geography (Australia/NZ), product mix (animal sera, plasma), and target customer base (IVD and pharma manufacturers).
• MP Biomedicals: Global life science distributor and manufacturer of biological and biochemical reagents, sera, and diagnostic inputs. Comparable in being a specialty B2B distributor of biological raw materials to research, IVD, and pharma customers, though with a broader portfolio.
• M bioserviceS: Austrian biotech services company that, per Biophyll's own website, jointly assists biotech firms worldwide in sourcing, importation, and handling of biological raw materials, including the Act-O2-Hem project. Operates in essentially the same niche (specialty biological sourcing/distribution for pharma and diagnostics) and is co-located in the DACH region.
• Serana: German manufacturer of animal sera and cell culture media used in diagnostics and research. Named project partner of Biophyll on hemoglobin-enzyme solutions, and competes head-to-head on sera and animal-derived biological inputs serving IVD and pharma customers.
• Gemini Bio-Products: US-based supplier of fetal bovine serum, animal sera, and cell culture media to life science research, IVD, and biopharma customers. Directly comparable in product mix (FBS, sera, specialty animal-derived inputs) and go-to-market (B2B distribution to pharma/diagnostic buyers).
• Atlanta Biologicals: US supplier of sera, plasma, and animal-derived biological products for cell culture, diagnostics, and research. Overlaps with Biophyll on serum and plasma product lines and the IVD/research customer base in North America.

Others

• ATCC (American Type Culture Collection): Non-profit biological resource center supplying authenticated cell lines, microbial cultures, and biological materials to research and industry. Not a direct competitor on sera distribution but serves an overlapping research and pharma customer base with standardized, traceable biological inputs and is often a reference standard Biophyll's customers benchmark against.

Broad incumbents

• Cytiva (Danaher): Global bioprocessing supplier (formerly GE Healthcare Life Sciences) of cell culture media, sera, filtration, and process consumables to biopharma manufacturers. Competes with Biophyll at the upper end on cell-culture-grade sera and bioprocess inputs sold to pharmaceutical manufacturers.
• Bio-Techne: Large publicly traded life sciences tools company (including R&D Systems, Tocris, ProteinSimple) supplying biological reagents, proteins, sera, and cell culture products to pharma, diagnostics, and research globally. Overlaps with Biophyll on biological raw materials and downstream pharma/IVD customers, but at much greater scale and with a much broader catalog.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biophyll

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about biophyll